Risks and management of pregnancy in women with epilepsy: a review

Authors

  • Mamta Mahajan Department of Obstetrics and Gynecology, Government Civil Hospital, Theog, District Shimla, Himachal Pradesh, India
  • Anita Pal Department of Obstetrics and Gynecology, Kamla Nehru State Hospital for Mother and Child, Indira Gandhi Medical College, Shimla, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20181319

Keywords:

Anti-epileptic drugs (AED), Congenital malformation, Epilepsy, Pregnancy

Abstract

Women with epilepsy (WWE) face certain challenges during their pregnancy. In the present article an effort has been made to review the information regarding the frequency of seizure in pregnancy, effects of epileptic seizure on fetus, complications during pregnancy and delivery, incidences of fetal congenital malformations and infant development. The article reviews these concerns with special emphasis on management of pregnancy. Recommendations concerning prenatal counselling, anti-epileptic drug management, breast feeding and contraception are also taken up in the later part of the article.

References

Thomas, SV, Sudevan, R, Saxena, V. Management of epilepsy and pregnancy. J Obstet Gynecol India. 2009;2:115-23.

Kaplan PW, Norwitz ER, Ben-Menachem E, Pennell PB, Druzin M, Robinson JN et al. Obstetrics risk for women with epilepsy during pregnancy. Epilepsy Behav. 2007;11:283-91.

Vajda FJ, Hitchcock A, Graham J, O'brien T, Lander C, Eadie M. Seizure control in antiepileptic drug‐treated pregnancy. Epilepsia. 2008 Jan 1;49(1):172-6.

Kevill JW, Gonzalez-Toledo E. Epilepsy and Pregnancy. Neurological Disorders Pregnancy 2011:91-121.

Tomson T, Palm R, Källén K, Ben‐Menachem E, Söderfeldt B, Danielsson B, Johansson R, Luef G, Öhman I. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia. 2007 Jun 1;48(6):1111-6.

Swartjes, JM, Gejin, HP Van. Pregnancy and epilepsy. Eur J Obstet Gynecol Reprod Biol. 1998;79:3-11.

Yerby MS, Kaplan P, Tran T. Risk and management of pregnancy in women with epilepsy. Cleve Clin J Med. 2004;71(2):S25-S37.

Thomas SV. Epilepsy and pregnancy. Curr Sci. 2002;82:720-30.

Hvas CL, Henriksen TB, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG. 2000 Jul;107(7):896-902.

Dolk H, McElhattan P. Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medication. J Med Genet. 2002;39:243-4.

Barrett C, Richens A. Epilepsy and pregnancy: Report of an epilepsy research foundation workshop. Epilepsy Res. 2003;52:147-87.

Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child. 1996;75:517-20.

Samren EB, Duijn CV, Koch S, Hiilesmaa VK, Klepel H, Bardy AH et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia. 1997 Sep;38(9):981-90.

Panigrahi I, Kalra J. Antiepileptic drug therapy and overview of fetal effects. J Indian Med Assoc. 2011;109:108-10.

Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of Treating epilepsy in pregnancy. Epilepsia, 2004;45(10):1171-5.

Nicholson A, Appleton RE, Chadwick DW, Smith DF. The relationship between treatment with valproate, lamotrigine and topiramate and the prognosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry. 2004;75:75-9.

Pennell PB, Gidal BE, Sabers A, Gordon J, Perucca E. Pharmacology of antiepileptic drugs during pregnancy and lactation. Epilepsy Behav. 2007 Nov;11(3):263-9.

Ohman I, Vitols S, Tomsom T. Lamotrigine in pregnancy: Pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia. 2000;41(6):709-13.

Moore, SJ, et al. A clinical study of 57 children with fetal anticonvulsant syndrome. J Med. Genet. 2000; 37:489-97.

Bridgette B. Management of epilepsy in pregnancy. Rec Adv Obstet and Gynecol. 2001;21:22-33.

Pennell PB. Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Curr. 2005;5(2):45-51.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360:1597-1605.

Öhman I, Vitols S, Luef G, Söderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia. 2002 Oct 1;43(10):1157-60.

Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2005;61(3):246-55.

Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS drugs. 2002;16(4):263-72.

Fairgrieve SD, Jackson M, Jonas P, Walshaw D, White K, Montgomery TL, Burn J et al. Population based prospective study of the care of women with epilepsy in pregnancy. BMJ. 2000;321:674-5.

Harden CL, Pennell PB, French JA, Davis A, Lau C, Llewellyn N, et al. Anti-mullerian hormone is higher in seizure-free women with epilepsy compared to those with ongoing seizures. Epilepsy Res. 2016;127:66-71.

Downloads

Published

2018-03-27

Issue

Section

Review Articles